Piece is a platform for investing in rented properties, offering monthly rental income and long-term appreciation for everyone.
Aerem is a Mumbai-based FinTech platform dedicated to promoting clean energy solutions for businesses and commercial enterprises. By facilitating the adoption of rooftop solar systems, Aerem enables organizations to significantly reduce electricity costs by up to 70%. The company utilizes a comprehensive installer network and offers financing options through its in-house non-banking financial company or partner banks, making it easier for businesses, particularly micro, small, and medium enterprises, to transition to solar energy. Aerem’s mission is to democratize access to clean energy and contribute to a sustainable future, achieving a positive impact on the environment, society, and economy through its innovative services. With its growing presence across India, Aerem is positioned to lead the charge in solar energy adoption.
TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.
RegCell
Seed Round in 2025
RegCell is a biotechnology company focused on developing innovative therapeutic technologies to address autoimmune diseases and cancer. The company specializes in creating advanced cell therapies that work by controlling and augmenting the immune system. RegCell's approach involves returning regulatory T cells and activating them in vitro, allowing for effective treatment options for patients facing these challenging health conditions. By targeting unmet medical needs, RegCell aims to improve patient outcomes and provide new hope for those suffering from autoimmune disorders and cancer.
issin
Venture Round in 2025
Developer of healthcare devices intended for weight management. The company's product is a bath mat that automatically tracks the weight of all the members of the family, records daily weight changes and provides data in the application synced with the mat and is equipped with various modes which fulfill the lifelong weight management needs of various stages of life including babies to elder people, enabling users to monitor their weight and body mass index for lifestyle improvement.
Eureka Robotics
Series A in 2024
Eureka Robotics is a company that specializes in developing advanced robotic technology aimed at automating tasks that require high accuracy and agility. The company offers software and systems designed to enhance productivity and safety while reducing operational costs across various industries, including healthcare, automotive, telecom, and aerospace. With a presence in Singapore, France, and Vietnam, along with distribution partnerships in China, Japan, and the United States, Eureka Robotics focuses on applications such as precision handling, assembly, inspection, and drilling. By leveraging cutting-edge research from institutions like NTU Singapore and MIT, Eureka Robotics enables clients to optimize their processes, allowing human workers to concentrate on strategic decision-making and creative endeavors, rather than routine tasks.
Liminal
Venture Round in 2024
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.
SUN METALON
Series A in 2024
SUN METALON is a manufacturer focused on advancing metal manufacturing through innovative technology. The company specializes in providing cost-effective solutions for decarbonizing the metal industry, primarily through recycling, refining, and forming processes. Additionally, SUN METALON develops three-dimensional printers capable of producing metal parts for local consumption, allowing for on-site fabrication. This approach enables clients to efficiently create metal products while significantly reducing costs. By combining sustainable practices with advanced manufacturing techniques, SUN METALON aims to transform the way metal parts are produced and consumed.
TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.
Quanmatic
Series A in 2024
Quanmatic is an information and technology company focused on developing algorithms and solutions that connect quantum technologies with real-world applications. It offers an experiential learning platform that includes tutorial content and demonstration applications targeting combinatorial optimization problems. This platform provides an interactive environment where users can input mathematical data and utilize quantum annealing machines directly through a web browser. By enabling users to address complex, large-scale problems, Quanmatic aims to enhance understanding and practical use of quantum computing technologies.
Celaid Therapeutics
Series A in 2024
Celaid Therapeutics is a regenerative medicine company focused on the development and commercialization of cell therapy products derived from human hematopoietic stem cells. The company employs advanced stem cell expansion technology to create innovative therapies, while also offering research and discovery support through specialized media reagents. Celaid Therapeutics aims to enhance medical practices in hematopoietic stem cell transplantation and cell therapy, incorporating gene-editing technology to improve treatment outcomes. By leveraging its expertise, the company addresses critical needs in regenerative medicine, providing valuable solutions for medical professionals.
Red Arrow Therapeutics
Seed Round in 2024
Developer of a healthcare technology designed to replace the traditional way of treating cancer treatment. The company aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity, helping the healthcare sector to overcome systemic toxicity and exhibiting strong anti-tumor efficacy in various tumor models both as monotherapy and in combination with immune checkpoint inhibitors.
SWAT Mobility
Venture Round in 2024
SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.
X Mile is an HR platform that connects logistics companies with drivers, focusing on addressing issues like labor shortages and low productivity. The company operates a SaaS non-desk platform designed to provide recruitment information for driver careers, mechanic careers, and construction careers. By specializing in these fields, X Mile supports agents in the logistics, automobile maintenance, and construction industries, helping them improve operational efficiency and increase sales through effective management support.
TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.
Alumnote
Seed Round in 2023
Alumnote is a provider of alumni association management software designed to assist educational institutions in managing their alumni networks online. The company focuses on enhancing loyalty among graduates and facilitating marketing efforts aimed at potential donors. By offering digital tools and support for donation acquisition, Alumnote aims to streamline fundraising activities and activate university alumni networks. Its services include community management efficiency improvements, digital transformation assistance, and support for building graduate databases. Through these efforts, Alumnote enables its clients to foster a culture of giving and accelerate the flow of funds within the educational sector in Japan.
Oxford Quantum Circuits
Series B in 2023
Oxford Quantum Circuits is a developer of advanced quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company focuses on creating unique superconducting circuits essential for quantum computation, ensuring high-quality qubit control and maintaining operational efficiency. Their quantum computers are fully integrated units, comprising the necessary control systems, hardware, and software, which enable customers to enhance their operations, innovate new methodologies, and tackle pressing issues. Through its pioneering technology, Oxford Quantum Circuits contributes to groundbreaking advancements that hold the potential for transformative impacts across various industries.
Obviously AI
Venture Round in 2023
Obviously AI, Inc. is a technology company founded in 2018 and based in Berkeley, California, specializing in cloud-based data science solutions. The company develops a platform that allows users to perform complex data analyses and generate predictions by posing natural language questions, without the need for coding expertise. By utilizing data science and machine learning, Obviously AI's platform interprets users' inquiries, retrieves the relevant data, and applies machine learning algorithms to deliver insights and predictions. This innovative approach enables businesses to understand customer behavior, identify target audiences, and enhance their marketing strategies, ultimately facilitating the transition of companies into AI-driven enterprises.
RICOS is a technology company focused on enhancing manufacturing processes through the integration of artificial intelligence, simulation, and high-performance computing. The company has developed an AI algorithm known as IsoGCN, which is specifically designed to work with simulation data, facilitating quicker and more interactive design and evaluation. RICOS aims to advance research and development in scientific computing technologies, including Computer-Aided Engineering (CAE), to enable their effective application in manufacturing environments. By providing a browser-based design and simulation platform, RICOS empowers researchers to conduct accurate calculations more efficiently, thereby realizing the potential for transformative advancements in manufacturing practices.
United Immunity
Venture Round in 2023
United Immunity, Co., Ltd. is a research and development company based in Tsu, Japan, specializing in the manufacture and sales of pharmaceuticals with a primary focus on cancer immunotherapy. Founded in November 2017, the company develops innovative nanoparticles and lipid nanoparticles aimed at targeting myeloid cells to treat cancer and infectious diseases. United Immunity's technology enables the delivery of various therapeutic agents directly to macrophages and dendritic cells, facilitating the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases.
Peach Cars
Seed Round in 2023
Peach Cars operates a used car marketplace designed to streamline the buying and selling of vehicles. The company focuses on providing a transparent and efficient experience through its user-friendly platform, which features verified listings of used cars. In addition to facilitating transactions, Peach Cars offers services related to car maintenance and secure payment processing. By leveraging IoT and machine learning technologies, the company aims to enhance the vehicle trading process specifically in sub-Saharan Africa, ensuring hassle-free interactions for customers.
Cellusion
Series C in 2023
Cellusion Inc. is a regenerative medicine company based in Tokyo, Japan, established in 2015. It focuses on research, development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells specifically for the treatment of bullous keratopathy. The company has developed a mass culture system for these cells, allowing for transplantation procedures that can significantly improve vision in affected patients. By using corneal endothelial cell substitutes derived from iPS cells, Cellusion provides a novel therapeutic solution that involves injecting the cells and replacing damaged corneal tissue, which is then manually sutured. This innovative approach aims to address the needs of patients suffering from this eye condition effectively.
Violet Therapeutics
Venture Round in 2023
Violet Therapeutics is a pre-clinical stage biotechnology company focused on drug discovery for central nervous system diseases. The company utilizes innovative platforms that identify, map, and analyze cellular connectomes through barcoded viral tracing, offering insights into cell-cell interactions at a single-cell level. This approach aims to facilitate advancements in the understanding and treatment of neuroinflammation. Co-founded by Mass General Brigham Ventures and researchers from Brigham & Women’s Hospital, Violet Therapeutics is committed to exploring novel therapeutic targets to develop effective treatments for complex neurological conditions.
Tricog Health
Series C in 2023
Tricog Health is a company that specializes in cardiac diagnostic tools aimed at addressing cardiovascular conditions through real-time identification and accurate analysis. Utilizing medical-grade artificial intelligence, Tricog improves cardiac care by bridging gaps in infrastructure, expertise, and efficiency within healthcare systems. The company offers virtual diagnostic tools and services that empower healthcare providers to make timely and precise diagnoses, ultimately enhancing patient outcomes. Tricog's innovative medical device facilitates real-time reporting and analysis of electrocardiography results without the need for additional hardware, ensuring early detection of potentially life-threatening cardiac events.
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
X Mile is an HR platform that connects logistics companies with drivers, focusing on addressing issues like labor shortages and low productivity. The company operates a SaaS non-desk platform designed to provide recruitment information for driver careers, mechanic careers, and construction careers. By specializing in these fields, X Mile supports agents in the logistics, automobile maintenance, and construction industries, helping them improve operational efficiency and increase sales through effective management support.
HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.
PaylessGate
Venture Round in 2022
PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.
SUN METALON
Venture Round in 2022
SUN METALON is a manufacturer focused on advancing metal manufacturing through innovative technology. The company specializes in providing cost-effective solutions for decarbonizing the metal industry, primarily through recycling, refining, and forming processes. Additionally, SUN METALON develops three-dimensional printers capable of producing metal parts for local consumption, allowing for on-site fabrication. This approach enables clients to efficiently create metal products while significantly reducing costs. By combining sustainable practices with advanced manufacturing techniques, SUN METALON aims to transform the way metal parts are produced and consumed.
Obniz is a technology company that specializes in providing a cloud-based Internet of Things (IoT) system, enabling real-time and bi-directional access to physical hardware via the cloud. Its platform allows users to remotely control sensors, actuators, and various machines, facilitating the construction and operation of systems for location information acquisition and environmental management. Obniz empowers clients to seamlessly connect their devices to the cloud, enhancing operational efficiency and enabling innovative applications in various industries.
Oxford Quantum Circuits
Series A in 2022
Oxford Quantum Circuits is a developer of advanced quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company focuses on creating unique superconducting circuits essential for quantum computation, ensuring high-quality qubit control and maintaining operational efficiency. Their quantum computers are fully integrated units, comprising the necessary control systems, hardware, and software, which enable customers to enhance their operations, innovate new methodologies, and tackle pressing issues. Through its pioneering technology, Oxford Quantum Circuits contributes to groundbreaking advancements that hold the potential for transformative impacts across various industries.
Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.
Frontier Field
Series B in 2022
Frontier Field is a venture company that brings the medical and healthcare fields together with the power of IT. It also engaged in the planning, development, sales, and maintenance of the nibyo mobile smartphone exclusively for medical institutions.
OriCiro Genomics
Series B in 2022
OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.
Eureka Robotics
Seed Round in 2022
Eureka Robotics is a company that specializes in developing advanced robotic technology aimed at automating tasks that require high accuracy and agility. The company offers software and systems designed to enhance productivity and safety while reducing operational costs across various industries, including healthcare, automotive, telecom, and aerospace. With a presence in Singapore, France, and Vietnam, along with distribution partnerships in China, Japan, and the United States, Eureka Robotics focuses on applications such as precision handling, assembly, inspection, and drilling. By leveraging cutting-edge research from institutions like NTU Singapore and MIT, Eureka Robotics enables clients to optimize their processes, allowing human workers to concentrate on strategic decision-making and creative endeavors, rather than routine tasks.
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
BUGWORKS Research
Series B in 2022
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
Eplane builds and develops electric air transportation systems.
The ePlane Company
Seed Round in 2022
ePlane aims to tackle urban road traffic congestion by introducing innovative flying solutions. Their flagship product aims to provide a safe, sustainable, and affordable flying experience, contributing to a future of urban mobility that is efficient and eco-friendly.
Cellusion
Venture Round in 2022
Cellusion Inc. is a regenerative medicine company based in Tokyo, Japan, established in 2015. It focuses on research, development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells specifically for the treatment of bullous keratopathy. The company has developed a mass culture system for these cells, allowing for transplantation procedures that can significantly improve vision in affected patients. By using corneal endothelial cell substitutes derived from iPS cells, Cellusion provides a novel therapeutic solution that involves injecting the cells and replacing damaged corneal tissue, which is then manually sutured. This innovative approach aims to address the needs of patients suffering from this eye condition effectively.
Forest Co., Ltd. is an e-commerce aggregator focused on identifying and promoting sustainable, high-quality products that embody the essence of Japan. The company employs a technology-driven platform to acquire and support third-party brands, leveraging a specialized team that tailors marketing strategies to the unique attributes of each brand. By utilizing a deep understanding of digital algorithms, Forest optimizes advertising efforts to facilitate growth and enhance the global market presence of its partners.
RICOS is a technology company focused on enhancing manufacturing processes through the integration of artificial intelligence, simulation, and high-performance computing. The company has developed an AI algorithm known as IsoGCN, which is specifically designed to work with simulation data, facilitating quicker and more interactive design and evaluation. RICOS aims to advance research and development in scientific computing technologies, including Computer-Aided Engineering (CAE), to enable their effective application in manufacturing environments. By providing a browser-based design and simulation platform, RICOS empowers researchers to conduct accurate calculations more efficiently, thereby realizing the potential for transformative advancements in manufacturing practices.
Charco Neurotech
Seed Round in 2021
Charco Neurotech is a medical technology company focused on creating non-invasive wearable devices aimed at enhancing the quality of life for individuals with Parkinson's disease. The company's primary innovation involves a wearable device that modulates sensory dysfunction, which aids users in improving their movement speed and overall mobility. By addressing specific challenges faced by those living with Parkinson's, Charco Neurotech seeks to empower individuals to maintain a more active and normal lifestyle.
ALGO ARTIS
Series A in 2021
ALGO ARTIS is a software company that specializes in optimizing various aspects of plant operations, including tanking, ship allocation planning, and logistics. By utilizing algorithmic methods and user-friendly artificial intelligence technology, ALGO ARTIS provides a consulting design system aimed at enhancing management and operational efficiency. The company's solutions facilitate the correct selection of technology and processes, allowing businesses to streamline their operations effectively. Through its innovative approach, ALGO ARTIS supports organizations in achieving improved performance and operational optimization.
Capex
Venture Round in 2021
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
OriCiro Genomics
Series B in 2021
OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.
VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.
PaylessGate
Seed Round in 2021
PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.
EditForce
Series A in 2021
EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. It specializes in developing innovative technologies for genome and RNA editing, particularly through the engineering of pentatricopeptide repeat (PPR) proteins. EditForce's advanced tools facilitate the manipulation of nucleic acids, enabling precise editing of DNA and RNA at a genomic scale. This technology is applicable across various fields, including biological research, medicine, agriculture, and bio-production, allowing for the development of drugs and genetically modified seeds. By providing alternative genome editing solutions, EditForce aims to advance scientific research and improve agricultural outcomes.
Startbahn
Series B in 2021
Startbahn, Inc. is a Tokyo-based company founded in 2014 that operates as a platform for artists in the digital age. It focuses on providing technology and infrastructure to support the art community globally. The company has developed Startbahn Cert., a service that issues blockchain certificates for artworks, and is working on Startrail, a blockchain infrastructure that underpins this certification system. Startbahn's offerings include a certificate management system that allows users to access registration information via smartphone and a marketplace for buyers to discover artworks. Additionally, the company engages in various activities such as artwork production, art direction, consulting, and design services, contributing to the broader art ecosystem.
Obviously AI
Seed Round in 2021
Obviously AI, Inc. is a technology company founded in 2018 and based in Berkeley, California, specializing in cloud-based data science solutions. The company develops a platform that allows users to perform complex data analyses and generate predictions by posing natural language questions, without the need for coding expertise. By utilizing data science and machine learning, Obviously AI's platform interprets users' inquiries, retrieves the relevant data, and applies machine learning algorithms to deliver insights and predictions. This innovative approach enables businesses to understand customer behavior, identify target audiences, and enhance their marketing strategies, ultimately facilitating the transition of companies into AI-driven enterprises.
DataFluct
Series A in 2021
DataFluct Inc. is a data science company based in Chiyoda City, Japan, founded in 2019 and operating as a subsidiary of Factorium Inc. The company specializes in providing data management and machine learning services aimed at addressing corporate and social challenges through innovative data science solutions. DataFluct offers a free satellite image search service that allows users to access and utilize satellite imagery. Its development focus is on sustainable algorithms that optimize solutions while considering environmental, social, and economic factors. By leveraging full-stack technology for data collection, storage, analysis, and utilization, DataFluct enables businesses to harness multimodal data effectively, allowing for predictive insights and the creation of new value from previously untapped information.
ImmunoScape
Venture Round in 2021
ImmunoScape is a biotechnology company specializing in immunomics, focused on advancing immune profiling and characterization of the human immune response with high precision. The company utilizes its Deep Immunomics platform, which integrates mass cytometry, single-cell sequencing, and proprietary computational bioinformatics tools to deliver detailed and reproducible immune profiling data. This innovative approach supports various therapeutic areas, particularly oncology and infectious diseases, by enhancing the understanding of immunotherapy safety and efficacy while aiding in the identification of drug targets. Additionally, ImmunoScape offers a suite of software tools for immune cell profiling and antigen-specific T-cell identification, providing valuable insights during the research and development phases of immunotherapy clinical trials.
Obniz is a technology company that specializes in providing a cloud-based Internet of Things (IoT) system, enabling real-time and bi-directional access to physical hardware via the cloud. Its platform allows users to remotely control sensors, actuators, and various machines, facilitating the construction and operation of systems for location information acquisition and environmental management. Obniz empowers clients to seamlessly connect their devices to the cloud, enhancing operational efficiency and enabling innovative applications in various industries.
HashPort
Venture Round in 2021
HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.
SWAT Mobility
Venture Round in 2021
SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.
Agara Labs is a technology company based in Bengaluru, India, founded in 2017. It specializes in automating customer support operations for large enterprises through its innovative end-to-end engagement system. The company's solutions leverage advanced technology to process multi-format data—including text, audio, and images—derived from customer interactions via emails, chats, phone calls, and social media in real time. Agara's autonomous voice conversation agent is designed to manage customer support calls without human intervention, particularly serving industries such as financial services, consumer products, and retail. This technology not only enhances the customer experience but also significantly reduces support costs by effectively addressing customer queries and feedback similar to a human agent.
Metcela Inc., founded in 2016 and based in Kawasaki-shi, Japan, is a clinical-stage biotech company focused on developing innovative therapies for cardiac diseases. The company specializes in fibroblast-based treatments, particularly utilizing VCAM-1-positive Cardiac Fibroblasts (VCF). Metcela's lead asset, MTC001, aims to repair damaged heart tissues and reestablish a favorable microenvironment by enhancing the healing capabilities of the patient's own cells. This approach provides an alternative treatment option for heart disease, offering patients an effective and cost-efficient solution for conditions like heart failure.
Capex
Venture Round in 2020
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
Japan Data Science Consortium
Series B in 2020
Japan Data Science Consortium Co. is a Tokyo-based company specializing in artificial intelligence, Internet of Things, and robotic services. Established in 2014, JDSC offers a range of solutions including demand forecasting, predictive maintenance, and digital transformation. The company also focuses on zero re-delivery systems, optical character recognition, and image recognition services. Targeting sectors such as healthcare, education, and retail, JDSC provides comprehensive consulting support that encompasses system construction and organizational process transformation, all aimed at generating tangible profit through the effective use of AI technology.
Epigeneron
Series B in 2020
Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.
BionicM is a Tokyo-based company that specializes in the research, development, and commercialization of advanced mobility devices that integrate robotics with the human body. Founded in 2018, BionicM focuses on creating high-performance robotic prostheses, including ankle-foot and knee joints, aimed at enhancing mobility for individuals with disabilities. The company has its roots in research conducted since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, where it leveraged cutting-edge robotics technology under the guidance of Professor Inaba. BionicM's innovative solutions enable users, whether handicapped or non-handicapped, to perform daily activities such as standing, walking, and climbing stairs, thereby significantly improving their quality of life.
bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms through single-cell technology, utilizing its proprietary database of natural microbial sequences, which is the largest of its kind. The company specializes in enzyme discovery and engineering, offering a variety of services including single-cell genomics, database screening, and wet lab evaluations of target sequences. Additionally, bitBiome aims to develop diagnostics and therapeutic solutions by analyzing microorganisms on a cell-by-cell basis, ultimately contributing to advancements in human health.
Tellus is a technology company that specializes in wireless, non-invasive health monitoring for elderly care facilities. It uses advanced sensor technology to continuously track vital signs and activities, providing real-time insights and alerts to caregivers. This enables better decision-making during emergencies or to prevent issues proactively, enhancing eldercare quality and operational efficiency.
ImmunoScape
Venture Round in 2020
ImmunoScape is a biotechnology company specializing in immunomics, focused on advancing immune profiling and characterization of the human immune response with high precision. The company utilizes its Deep Immunomics platform, which integrates mass cytometry, single-cell sequencing, and proprietary computational bioinformatics tools to deliver detailed and reproducible immune profiling data. This innovative approach supports various therapeutic areas, particularly oncology and infectious diseases, by enhancing the understanding of immunotherapy safety and efficacy while aiding in the identification of drug targets. Additionally, ImmunoScape offers a suite of software tools for immune cell profiling and antigen-specific T-cell identification, providing valuable insights during the research and development phases of immunotherapy clinical trials.
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.
TXP Medical
Series A in 2020
TXP Medical Inc., established in 2017 and headquartered in Bunkyo, Japan, specializes in developing and selling patient information recording and management systems. The company's primary product is NEXTStage ER, a platform supporting both medical record input and research, along with NSER mobile for voice-command and image OCR-based patient data entry. Additionally, TXP Medical offers Self Assessment System enabling patients to input their own data. These solutions aim to connect medical information across different fronts, fostering data-driven decision-making and improving overall healthcare outcomes.
BUGWORKS Research
Series B in 2020
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
Nelumbo Inc. is a materials innovation company based in Menlo Park, California, founded in 2015. It specializes in manufacturing thin superomniphobic nanocoatings designed for air conditioning cooling coil fins and refrigeration units. The company's key products include Ice-Nein, which helps prevent frost buildup on refrigeration equipment, thereby reducing defrosting downtime, and Omniphobe, which enhances the efficiency of cooling coils in air conditioning systems. Nelumbo focuses on developing advanced heat exchangers for the heating, ventilation, and air conditioning (HVAC) market, aiming to improve energy performance while minimizing corrosion. Through its innovative approach, the company seeks to address significant opportunities for reducing carbon emissions and energy consumption on a global scale.
Tricog Health
Series B in 2020
Tricog Health is a company that specializes in cardiac diagnostic tools aimed at addressing cardiovascular conditions through real-time identification and accurate analysis. Utilizing medical-grade artificial intelligence, Tricog improves cardiac care by bridging gaps in infrastructure, expertise, and efficiency within healthcare systems. The company offers virtual diagnostic tools and services that empower healthcare providers to make timely and precise diagnoses, ultimately enhancing patient outcomes. Tricog's innovative medical device facilitates real-time reporting and analysis of electrocardiography results without the need for additional hardware, ensuring early detection of potentially life-threatening cardiac events.
OPALai offers AI-driven digital financial products working on commodities and FX markets for pricing, hedging, and trading.
VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.
Goryo Chemical
Venture Round in 2019
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.
SWAT Mobility
Series A in 2019
SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.
Algal Bio
Venture Round in 2019
Algal Bio Co., Ltd., established in 2018, is a Japanese company specializing in the research, development, production, and sale of algae and its components. Headquartered in Kashiwa, Japan, the company focuses on extracting rare fatty acids and carotenoids from algae, operating within food processing, importing, exporting, and distributing algae-related ingredients. Algal Bio was founded upon two decades of research from the University of Tokyo, aiming to harness microalgae's potential as functional food ingredients.
Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.
Retrieva
Venture Round in 2019
Retrieva, Inc. is a technology company based in Tokyo, Japan, specializing in the development of artificial intelligence-based software solutions for call centers. Founded in 2016, the company harnesses natural language processing and machine learning to create innovative products that enhance communication and operational efficiency. Its offerings include Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, which provides analytical insights. Retrieva's technology is designed to address enterprise customer challenges by delivering user-friendly services that improve inquiry analysis and response support in call center environments.
Adacotech
Venture Round in 2019
Adacotech is a company focused on the development and manufacturing of advanced video surveillance systems and anomaly detection software. It offers a unique system that utilizes proprietary algorithms to monitor events continuously for 24 hours while maintaining real-time performance. Adacotech's technology incorporates capabilities for product inspection and abnormality detection in manufacturing processes, as well as the inspection of social infrastructure. By leveraging inputs from images, videos, sounds, and sensors, the company's solutions enable clients to conduct primary screenings effectively. The product development process is managed in-house, ensuring that all aspects, from the source technology to the application programming interface, are controlled by Adacotech.
Mujin
Venture Round in 2019
Mujin Inc. is a Tokyo-based company focused on providing innovative solutions for industrial robotics and factory automation. Founded in 2011, Mujin develops intelligent robot controllers that serve as a universal platform for various industrial robots, addressing the adaptability limitations of conventional systems. The company's offerings include the Mujin Controller Sim for programming robots, Mujin Scanner for 3D modeling, Pick Worker for bin-picking with real-time motion planning, and Laser Worker for laser cutting. Mujin's technology streamlines processes in logistics and manufacturing, automating tasks that are typically performed by humans. Additionally, the company provides services such as intelligent robot system design, motion planning, and flexible motion control solutions applicable to a range of robotic and CNC machines. By integrating advanced motion planning technology and supporting various machine vision systems, Mujin enhances productivity and optimizes operations in complex environments.
OriCiro Genomics
Series A in 2019
OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.
Startbahn
Series A in 2019
Startbahn, Inc. is a Tokyo-based company founded in 2014 that operates as a platform for artists in the digital age. It focuses on providing technology and infrastructure to support the art community globally. The company has developed Startbahn Cert., a service that issues blockchain certificates for artworks, and is working on Startrail, a blockchain infrastructure that underpins this certification system. Startbahn's offerings include a certificate management system that allows users to access registration information via smartphone and a marketplace for buyers to discover artworks. Additionally, the company engages in various activities such as artwork production, art direction, consulting, and design services, contributing to the broader art ecosystem.
EditForce
Corporate Round in 2019
EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. It specializes in developing innovative technologies for genome and RNA editing, particularly through the engineering of pentatricopeptide repeat (PPR) proteins. EditForce's advanced tools facilitate the manipulation of nucleic acids, enabling precise editing of DNA and RNA at a genomic scale. This technology is applicable across various fields, including biological research, medicine, agriculture, and bio-production, allowing for the development of drugs and genetically modified seeds. By providing alternative genome editing solutions, EditForce aims to advance scientific research and improve agricultural outcomes.
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.
BionicM
Seed Round in 2019
BionicM is a Tokyo-based company that specializes in the research, development, and commercialization of advanced mobility devices that integrate robotics with the human body. Founded in 2018, BionicM focuses on creating high-performance robotic prostheses, including ankle-foot and knee joints, aimed at enhancing mobility for individuals with disabilities. The company has its roots in research conducted since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, where it leveraged cutting-edge robotics technology under the guidance of Professor Inaba. BionicM's innovative solutions enable users, whether handicapped or non-handicapped, to perform daily activities such as standing, walking, and climbing stairs, thereby significantly improving their quality of life.
PharmaBio
Venture Round in 2019
PharmaBio Corporation is a healthcare company specializing in the contract development and manufacturing of cellular and tissue-based products. Founded in 1978 and headquartered in Nagoya, Japan, with an administrative branch in Tokyo, the company focuses on the development of cell-based investigational new drugs and offers a range of services including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a GMP-compliant facility for the storage of cell-based drugs and test specimens, ensuring high standards of safety and quality. Additionally, the company provides strategic development consultation to support regulatory processes in cell and tissue-based medicine, aiming to enhance medical and social progress through its innovative products and services.
bitBiome
Seed Round in 2019
bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms through single-cell technology, utilizing its proprietary database of natural microbial sequences, which is the largest of its kind. The company specializes in enzyme discovery and engineering, offering a variety of services including single-cell genomics, database screening, and wet lab evaluations of target sequences. Additionally, bitBiome aims to develop diagnostics and therapeutic solutions by analyzing microorganisms on a cell-by-cell basis, ultimately contributing to advancements in human health.
Obniz is a technology company that specializes in providing a cloud-based Internet of Things (IoT) system, enabling real-time and bi-directional access to physical hardware via the cloud. Its platform allows users to remotely control sensors, actuators, and various machines, facilitating the construction and operation of systems for location information acquisition and environmental management. Obniz empowers clients to seamlessly connect their devices to the cloud, enhancing operational efficiency and enabling innovative applications in various industries.
ImmunoScape
Seed Round in 2018
ImmunoScape is a biotechnology company specializing in immunomics, focused on advancing immune profiling and characterization of the human immune response with high precision. The company utilizes its Deep Immunomics platform, which integrates mass cytometry, single-cell sequencing, and proprietary computational bioinformatics tools to deliver detailed and reproducible immune profiling data. This innovative approach supports various therapeutic areas, particularly oncology and infectious diseases, by enhancing the understanding of immunotherapy safety and efficacy while aiding in the identification of drug targets. Additionally, ImmunoScape offers a suite of software tools for immune cell profiling and antigen-specific T-cell identification, providing valuable insights during the research and development phases of immunotherapy clinical trials.
Socium
Venture Round in 2018
Socium Inc. is a Japan-based company specializing in AI-powered drug discovery and development. It focuses on creating first-in-class small molecules and has a diverse development portfolio that targets over 23 diseases, including oncology and rare diseases. Utilizing a systems biology approach, Socium leverages advanced algorithms and machine learning to streamline the traditional drug discovery process by employing an in-silico system. This innovative method allows the company to identify drug discovery targets more quickly, often within a few months. Additionally, Socium analyzes a wide array of omics data to profile entire diseases rather than concentrating solely on related compounds, which enhances the efficacy and breadth of its research efforts. By integrating drug repositioning strategies, Socium also seeks to uncover new therapeutic uses for existing commercial drugs, thereby contributing to advancements in healthcare.
Locix, Inc. specializes in developing advanced technology products and services aimed at enhancing spatial and contextual awareness for smart homes and commercial applications. The company offers a range of solutions, including the Locix HD Vision, which provides visual insights for monitoring and analysis, and the Locix Local Positioning System, a comprehensive solution that delivers precise location determination for Wi-Fi-enabled devices. Additional offerings include SmartDock, which utilizes AI for real-time monitoring of loading and unloading efficiencies, and SmartLPS, which digitizes and analyzes operations in warehouses. Locix also provides remote monitoring solutions applicable to various environments such as warehouses and construction sites, as well as a contact tracing solution for COVID-19. Founded in 2015 and based in Silicon Valley, Locix aims to deliver actionable insights through the integration of location, visual, and sensor data with advanced analytics. The company was previously known as Dragonfly Technology Inc. before rebranding in 2017.
Neural Pocket
Venture Round in 2018
Neural Pocket Inc. is a Tokyo-based company that specializes in proprietary AI technologies focused on image and video analysis. Founded in 2018 and previously known as Fashion Pocket Inc., the company offers a wide range of services aimed at enhancing smart cities and urban spaces. Its technologies facilitate object detection, classification, spatial recognition, and behavioral analysis, which are applied in sectors such as mobility, infrastructure, and security. Additionally, Neural Pocket provides digital signage solutions for advertisers, developers, and commercial facilities, as well as AI-driven fashion trend analysis by synthesizing data from social networking services and shopping sites. By leveraging edge computing technology, Neural Pocket aims to support the digitalization of various environments, including factories, warehouses, and retail spaces.
BUGWORKS Research
Series A in 2018
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
AI inside
Venture Round in 2018
AI Inside Inc. is a Tokyo-based company specializing in artificial intelligence and software development, particularly focusing on optical character recognition (OCR) services. Founded in 2015, AI Inside is dedicated to facilitating the digital transformation of society by converting various forms of information into digital data. The company offers an AI-powered platform known as the DX Suite, which aims to enhance productivity across different sectors. Through its innovative algorithms, AI Inside contributes to the advancement of a digital society by streamlining data processing and improving operational efficiency for its clients.
Nohla Therapeutics
Series B in 2018
Nohla Therapeutics, Inc., established in 2015 and headquartered in Seattle, Washington, specializes in developing and manufacturing ex vivo expanded universal donor cellular therapies. The company's core technology enables the expansion of key cancer-fighting cells from umbilical cord blood, eliminating the need for HLA matching. Nohla offers programs such as Natural Killer (NK) cell therapy and Dilanubicel, a universal donor hematopoietic stem and progenitor cell product used for treating chemotherapy-induced neutropenia and other indications. Its products are manufactured and cryopreserved in advance, ensuring immediate availability for patient treatment.
Startbahn
Seed Round in 2018
Startbahn, Inc. is a Tokyo-based company founded in 2014 that operates as a platform for artists in the digital age. It focuses on providing technology and infrastructure to support the art community globally. The company has developed Startbahn Cert., a service that issues blockchain certificates for artworks, and is working on Startrail, a blockchain infrastructure that underpins this certification system. Startbahn's offerings include a certificate management system that allows users to access registration information via smartphone and a marketplace for buyers to discover artworks. Additionally, the company engages in various activities such as artwork production, art direction, consulting, and design services, contributing to the broader art ecosystem.
Elixirgen Therapeutics
Series A in 2018
Elixirgen Therapeutics, LLC is a biotechnology company based in Baltimore, Maryland, that specializes in developing stem cell therapies aimed at curing various diseases, including aging-associated conditions and syndromes such as Alzheimer's disease. Founded in 2017, the company utilizes its proprietary ZSCAN4 protein, which enhances the developmental potential of embryonic stem cells and reactivates early embryonic genes during the production of induced pluripotent stem cells. Elixirgen Therapeutics focuses on regenerative and rejuvenative medicine by conducting research in both fundamental science and practical applications of its technologies. The company operates within the Science + Technology Park at Johns Hopkins, providing a conducive research environment for its scientists. By leveraging the intellectual property and therapy-related assets inherited from its parent company, Elixirgen, LLC, Elixirgen Therapeutics aims to create innovative protein-based therapies that target chronic telomere diseases and improve overall body immunity.
Fressets
Corporate Round in 2018
Fressets, Inc., established in 2017 and based in Tokyo, Japan, specializes in developing cryptocurrency wallet systems for virtual currency exchanges. The company's core business is an enterprise wallet management (EWM) system, primarily serving cryptocurrency exchanges and custodians. This system employs multisignature addresses and secure hardware for key storage, ensuring robust security against hacker threats. It combines the advantages of secure cold wallets and convenient hot wallets, providing clients with a balance of security and scalability for smooth cryptocurrency transactions.
Mirtel
Venture Round in 2018
MiRTeL Co., Ltd is a healthcare technology company based in Hiroshima, Japan, founded in 2012. The company specializes in gene testing services, providing clinical testing aimed at early disease detection, including cancer and genetic disorders. In addition to its testing services, MiRTeL distributes supplements to promote overall health. By facilitating health examinations and enabling healthcare organizations to identify health issues at an early stage, MiRTeL contributes to improved patient longevity and reduced medical expenses.
Aidemy Inc. is a Tokyo-based company that specializes in providing online artificial intelligence (AI) programming services and solutions. Founded in 2014, Aidemy offers an all-in-one web platform where individuals can learn AI technology through practical applications. The platform includes comprehensive teaching materials and a programming execution environment, enabling users to engage with AI concepts, such as blockchain technology and consensus algorithms. Aidemy's services cater to various clients, including corporations in the manufacturing industry, small businesses, and university laboratories. In addition to its educational offerings, the company provides Aidemy Business, an online learning platform designed to support the development of digital talent and reskilling efforts within organizations. Furthermore, Aidemy offers Modeloy, a DX consulting service that assists companies in human resource development, problem selection, and the implementation of digital transformation initiatives.